Biotie Therapies Corp (BTH1V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Biotie Therapies Corp (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as parkinsons disease, alzheimers disease, primary sclerosing cholangitis and other cognitive disorders; and inflammatory and fibrotic diseases. Its products under clinical development include Selincro, an opioid receptor ligand; Tozadenant, an innovative A2a antagonist; SYN120, a selective 5-HT6 receptor antagonist; and BTT1023, a monoclonal antibody, among others. The company has presence in Finland and the US. Biotie is headquartered in Turku, Finland.
Biotie Therapies Corp (BTH1V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Biotie Therapies Corp (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as parkinsons disease, alzheimers disease, primary sclerosing cholangitis and other cognitive disorders; and inflammatory and fibrotic diseases. Its products under clinical development include Selincro, an opioid receptor ligand; Tozadenant, an innovative A2a antagonist; SYN120, a selective 5-HT6 receptor antagonist; and BTT1023, a monoclonal antibody, among others. The company has presence in Finland and the US. Biotie is headquartered in Turku, Finland.
Biotie Therapies Corp (BTH1V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 3
List of Figures 4
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biotie Therapies Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
H. Lundbeck Amends Licensing Agreement With Biotie Therapies For Selincro 10
Equity Offering 11
Biotie Therapies Raises USD56.6 Million in Public Offering of ADSs 11
Biotie Therapies Completes Private Placement Of Shares For US$25 Million 12
Biotie Therapies Completes Private Placement Of Treasury Shares For US$37.4 Million 13
Debt Offering 14
Biotie Therapies to Raise USD45.6 Million in Private Placement of Notes and Warrants 14
Acquisition 16
Acorda Therapeutics Acquires Biotie Therapies in Tender Offer 16
Lundbeck Acquires 4.6% Stake In Biotie Therapies For US$13 Million 18
Biotie Therapies Acquires Synosia Therapeutics 19
Biotie Therapies Corp - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Jul 28, 2016: Biotie Therapies Interim Report for the reporting period January 1 - June 30, 2016 25
May 12, 2016: Biotie Interim Report 1 January - 31 March 2016 33
Corporate Communications 39
Jun 29, 2016: Biotie Therapies Announces Changes In The Management Team 39
Jun 13, 2016: Biotie Therapies Announces That the Delisting of Its American Depositary Shares from NASDAQ Global Select Market Has Become Effective 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List Of Tables
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biotie Therapies Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biotie Therapies Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
H. Lundbeck Amends Licensing Agreement With Biotie Therapies For Selincro 10
Biotie Therapies Raises USD56.6 Million in Public Offering of ADSs 11
Biotie Therapies Completes Private Placement Of Shares For US$25 Million 12
Biotie Therapies Completes Private Placement Of Treasury Shares For US$37.4 Million 13
Biotie Therapies to Raise USD45.6 Million in Private Placement of Notes and Warrants 14
Acorda Therapeutics Acquires Biotie Therapies in Tender Offer 16
Lundbeck Acquires 4.6% Stake In Biotie Therapies For US$13 Million 18
Biotie Therapies Acquires Synosia Therapeutics 19
Biotie Therapies Corp, Key Competitors 22
Biotie Therapies Corp, Key Employees 23
Biotie Therapies Corp, Other Locations 24
List Of Figures
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biotie Therapies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
RELATED REPORTS
SAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
